ABSTRACT
This report describes a case of direct duodenal invasion of hepatocellular carcinoma with massive intermittent gastrointestinal (GI) bleeding. Progressive anemia was intractable by supportive therapy alone, and repeated blood transfusion was necessary. Transcatheter arterial embolization was finally carried out, which dramatically reduced the amount of transfusion. Owing to severe blood loss, patients with GI tract involvement generally have a poor prognosis.
Subject(s)
Carcinoma, Hepatocellular/pathology , Duodenal Diseases/pathology , Embolization, Therapeutic , Gastrointestinal Hemorrhage/therapy , Liver Neoplasms/pathology , Angiography , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/diagnostic imaging , Duodenal Diseases/diagnostic imaging , Duodenal Diseases/etiology , Endoscopy, Digestive System , Fatal Outcome , Follow-Up Studies , Gastrointestinal Hemorrhage/etiology , Humans , Liver Neoplasms/complications , Liver Neoplasms/diagnostic imaging , Male , Middle Aged , Neoplasm Invasiveness , Tomography, X-Ray ComputedABSTRACT
We studied the tissue plasminogen activator (t-PA) levels in the plasma of patients with acute hepatitis (AH), severe acute hepatitis (AHs) and fulminant hepatitis (FH). Plasma t-PA levels were measured consecutively on the first, third and seventh days of hospitalization. Plasma t-PA levels were markedly higher in AHs and FH than in AH (p < 0.05, p < 0.01, respectively) on the first day, but did not differ significantly between AHs and FH on this day. The t-PA levels decreased markedly on the third and seventh days in AHs (both p < 0.05), but did not change from the first day to the third and seventh days in FH. The t-PA levels on the third and seventh days were higher in FH than in AHs (both p < 0.05). There was a significant increase in the plasma t-PA level before an episode of encephalopathy in FH compared with levels in AHs. These observations suggest that t-PA level may be useful as a prognostic parameter in patients with acute hepatic injury.
Subject(s)
Hepatitis/diagnosis , Tissue Plasminogen Activator/blood , Acute Disease , Adolescent , Adult , Clinical Enzyme Tests , Female , Humans , Male , Middle AgedABSTRACT
The association between the actual status of cryoglobulins (CGs) expression in hepatitis C-related chronic liver disease (C-CLD) and different types of liver pathology, HCV-RNA titers and genotypes was investigated. Sixteen out of 1340 ordinary clinical specimens were CGs-positive (1%), and in 8 of them (50%) the patients blood was HCV-RNA positive. CGs was detected in 63% of C-CLD patients as a whole, but when compared with the histological findings in the liver, it was 88% in F3, and 92% in A3, and thus high percentages were detected in patients with progression of liver fibrosis and patients with strong activity. Serum IgG, IgM, transaminase and gamma-GTP levels were significantly higher in the patients with CGs, and their RA test and C3dCIC levels tended to be higher, but the differences were not significant, and no association was found with the anti-nuclear antibody positive level, or the HCV-RNA titers or genotypes. Based on the above, there was a clear involvement of HCV infection, especially the activity and histological progression of hepatitis in CGs formation in Japan as well, but there were few extrahepatic manifestations, suggesting differences in CGS levels and immune response to CGs from cases in Western countries.
